Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 alpha variant: is it really more deadly? A population level observational study

View ORCID ProfileCandace Makeda Moore, View ORCID ProfileRuslan Sergienko, View ORCID ProfileRonen Arbel
doi: https://doi.org/10.1101/2021.08.17.21262167
Candace Makeda Moore
1Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Candace Makeda Moore
  • For correspondence: doctormakeda@gmail.com
Ruslan Sergienko
2Department of Health Policy and Management, Ben-Gurion University of the Negev, Beer Sheva, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ruslan Sergienko
Ronen Arbel
1Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ronen Arbel
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2021.08.17.21262167
History 
  • August 18, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Candace Makeda Moore, MD.1,*,
  2. Ruslan Sergienko, MA2 and
  3. Ronen Arbel, PhD.1
  1. 1Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel
  2. 2Department of Health Policy and Management, Ben-Gurion University of the Negev, Beer Sheva, Israel
  1. ↵*Corresponding author:
    Candace Makeda Moore, M.D., Research Coordinator, Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel Tel: (972) 52 353 1419; Fax: (972) 3 6916340; E-mail: doctormakeda{at}gmail.com
Back to top
PreviousNext
Posted August 18, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 alpha variant: is it really more deadly? A population level observational study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 alpha variant: is it really more deadly? A population level observational study
Candace Makeda Moore, Ruslan Sergienko, Ronen Arbel
medRxiv 2021.08.17.21262167; doi: https://doi.org/10.1101/2021.08.17.21262167
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 alpha variant: is it really more deadly? A population level observational study
Candace Makeda Moore, Ruslan Sergienko, Ronen Arbel
medRxiv 2021.08.17.21262167; doi: https://doi.org/10.1101/2021.08.17.21262167

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9758)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2304)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1554)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11634)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2140)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2173)
  • Public and Global Health (4648)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)